Clinical Trial Update: Apomorphine in Parkinson's Disease Patients With Visual Hallucinations [Phase 2]

View source ↗

Summary

Clinical trial update describes a Phase 2 study of apomorphine in Parkinson's disease patients experiencing visual hallucinations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Parkinson's Disease, Hallucinations, Visual | Phase 2 | Status: UNKNOWN